Archax, the first digital securities exchange to receive regulation from the UK’s Financial Conduct Authority, is bringing its tokenization engine to the Aptos blockchain. The integration will deliver more than 100 tokenized securities onchain, starting with MembersCap’s Tokenized Global Reinsurance Income Fund, known as MCM Fund I.

The network already hosts participation from BlackRock, Franklin Templeton, and Apollo, with nearly $1 billion in RWA-backed assets and $50 billion in monthly stablecoin volume.

What the integration actually does

Archax supports the full lifecycle of digital securities: issuance, trading, and custody, all within a regulated framework. The integration means that tokenized funds and equities issued through Archax will live natively on the Aptos chain. Institutional investors get a compliant on-ramp to blockchain-based finance.

MCM Fund I, the reinsurance income fund from MembersCap, serves as the inaugural product. Reinsurance is insurance that insurance companies buy.

Graham Rodford, CEO of Archax, has emphasized that regulatory compliance is the non-negotiable ingredient for institutional participation in tokenized assets.

Aptos and the RWA land grab

Aptos has been assembling a roster that includes BlackRock, Franklin Templeton, and Apollo. The nearly $1 billion in RWA-backed assets already on Aptos gives the chain a meaningful head start. Archax received its FCA designation back in 2020, making it one of the longest-standing regulated players in the digital asset space.

Ryan Zega, Head of Structured Finance at Aptos Labs, has pointed to the need for secure infrastructure capable of handling regulated products.

What this means for investors

Over 100 tokenized securities coming onchain through a regulated exchange is the kind of pipeline that turns theoretical market projections into real products.

One risk to monitor: regulatory fragmentation. Archax holds an FCA license, which carries weight in the UK and across parts of Europe. Whether that regulatory credential translates seamlessly to US or Asian markets remains an open question. Institutional investors with global mandates will need clarity on cross-border recognition before committing significant capital.